Short description
Innate Pharma is a biopharmaceutical company developing immunotherapy drug candidates for the treatment of cancer and inflammatory diseases.
Description
Innate Pharma S.A. is a biopharmaceutical company developing first-in-class immunotherapy drug candidates for cancer and inflammatory diseases.
The Company specializes in the development of novel monoclonal antibodies targeting receptors and pathways controlling the activation of innate immunity cells. Its innovative approaches have led to licensing agreements with Novo Nordisk A/S and Bristol-Myers Squibb.
Last funding
Blurry Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Marseille, Provence-Alpes-Cote d'Azur, France, Europe
Founded on
January 1, 1999
Exited on
October 17, 2019
Went public on
October 17, 2019
Stock symbol
IPHA
Non-profit?
No
Acquired?
No
Employees count
51-100
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noaccess, Blurry Noaccess, Noway Youcantaccess, Nopepepe, Absolutely Noaccess, Noway Youcantaccess, Nopepepe, No Way, Nopepepe, Noaccess, No Way, Cannot Access, Noway Youcantaccess, Noaccess
Sign in for full access
Founders
Alessandro Moretta, Eric Vivier, François Romagne, Hervé Brailly, Jean Fournie, Marc Bonneville